Inception Return
(12/17/2001)
|
8.45 %
|
YTD Return
|
8.61 %
|
|
NAVPS
(3/27/2024)
|
$44.74
|
Change
|
$0.45 / 1.01 %
|
|
Growth of $10,000
(As of February 29, 2024)
|
MER
|
0.00 %
|
Assets ($mil)
|
$147.67
|
Rank (1Yr)
|
88/178
|
Std Dev (3Yr)
|
16.69 %
|
Volatility Ranking (3Yr)
|
5/10
|
RRSP Eligibility
|
Yes
|
Load
|
No Load
|
Max Front End
|
-
|
Max Back End
|
-
|
Sales Status
|
Open
|
|
Objective
This fund’s objective is to obtain maximum long-term capital growth. It invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry. This includes companies that provide goods and services to these companies and companies that the portfolio adviser believes would benefit from developments in the health sciences industry.
|
Fund Manager
CI Global Asset Management
Portfolio Manager
Peter Hofstra, CI Global Asset Management
Kevin McSweeney, CI Global Asset Management
Greg Quickmre, CI Global Asset Management
Sub-Advisor
Data not available
|
Asset Allocation
(As of February 29, 2024)
|
Sector Allocation
(As of February 29, 2024)
|
Geographic Allocation
(As of February 29, 2024)
|
Top 10 Holdings
Name | Asset | Sector | Geographic | Percent |
Eli Lilly and Co | US Equity | Healthcare | United States | 10.26% |
Humana Inc | US Equity | Healthcare | United States | 8.72% |
UnitedHealth Group Inc | US Equity | Healthcare | United States | 7.39% |
Merck & Co Inc | US Equity | Healthcare | United States | 6.31% |
SPDR S&P Biotech ETF (XBI) | US Equity | Exchange Traded Fund | United States | 5.04% |
Zoetis Inc Cl A | US Equity | Healthcare | United States | 4.78% |
AstraZeneca PLC | International Equity | Healthcare | European Union | 4.69% |
Abbvie Inc | US Equity | Healthcare | United States | 4.22% |
Stryker Corp | US Equity | Healthcare | United States | 3.66% |
Boston Scientific Corp | US Equity | Healthcare | United States | 3.65% |
Performance Data
(As of February 29, 2024)
|
Return (%)
|
Annualized Return (%)
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
Fund
|
5.73
|
9.21
|
9.52
|
8.61
|
17.46
|
5.20
|
7.43
|
5.58
|
Benchmark
|
1.82
|
6.39
|
6.99
|
2.38
|
9.19
|
9.01
|
9.29
|
7.37
|
Quartile Ranking
|
2
|
3
|
3
|
2
|
2
|
2
|
3
|
4
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
Fund
|
5.07
|
1.16
|
2.28
|
13.85
|
14.63
|
3.59
|
9.08
|
-17.14
|
16.94
|
22.61
|
Benchmark
|
11.75
|
-5.84
|
25.09
|
5.60
|
22.88
|
-8.89
|
9.10
|
21.08
|
-8.32
|
10.55
|
Quartile Ranking
|
3
|
1
|
4
|
3
|
4
|
2
|
4
|
4
|
3
|
2
|